Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Expectations from Union Budget 2022 by Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd - The Pharma Times | Pharma & Health Care News Portal
Budget

Expectations from Union Budget 2022 by Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd

New Delhi, January 29, 2022: Government is required to stimulate growth and boost investment with confidence from both the public and private sector in the Union Budget 2022. Special emphasis is required for job creation, lifting consumption & sentiments and building infrastructure in priority sectors – Education, Health, Rural & MSME. With no social security mechanism for people at large, inadequate public infrastructure the middle-class taxpayers were affected the worst and have high hopes from the Government.

Healthcare sector will look for higher allocation towards production Linked Incentive schemes to encourage capacity expansion of sensitive APIs, complex excipients, drug intermediates etc. Interest subsidies and restoration of weighted tax deduction u/s 35(2AB) to encourage innovation and R&D are some of the key measures required for the sector. We need to create an ecosystem for research and innovation in the country which is ignored to an extent. Covid taught very important lessons of self-reliance and innovation in the pharma sector, especially in the APIs to reduce dependence on China.  

Funds allocated for healthcare as a percentage of GDP at 1.5% continue to be lower compared to most developing nations. Keeping in mind the current pandemic situation, it is need of the hour for the government to increase the allocation towards health infrastructure across the entire infrastructure chain, specifically in tier 2 and tier 3 cities and immunisation. Higher allocation to the sector is also necessary to enable the government to achieve its target to spend 2.5% of GDP on healthcare by 2025.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Gleneagles Hospital Mumbai Introduces Pediatric Bone Marrow Transplant (BMT) Facility

New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…

5 hours ago

Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT);

Achieves significant advancement in Cancer Treatment to Enhance Quality of Life  As per the National…

1 day ago

Two Complex Robotic Kidney Transplant Surgeries Successfully Performed at Fortis Hospital Bannerghatta Road

-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…

2 days ago

On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology Nurses

Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…

3 days ago

SOCC Unveils A New Era In Paediatric Care: Second Opinion Online Consultations For Children

Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…

6 days ago

India’s First Lady Surgeon Trained in Robotic Breast Surgery Performs Karnataka’s 1st Robotic Nipple Sparing Mastectomy

Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…

1 week ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420